Thu, Jan 17, 2019
HUL Q3 results: Transaction of this deal is an all-equity merger with 4.39 shares of HUL being allotted for every share in GSK CH India.
More >
The company missed analysts estimates in Q3FY19, as a Bloomberg poll of experts predicted revenue and net profit to come in at Rs 9,440 crore and Rs 1,450 crore respectively.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
